Veri-te™
High-purity, > 98% trans-resveratrol backed by proprietary clinical studies
RESHAW clinical study, with Veri-te™
The RESHAW (Resveratrol Supporting Healthy Aging in Women) clinical study followed 125 postmenopausal women during a 24-month crossover comparison. Volunteers were randomized to take two capsules containing 75mg of Veri-te™ resveratrol daily or a matching placebo supplement for 12 months, followed by the alternate treatment for a further 12 months.
Significant benefits were seen for cognitive & cerebrovascular function, longevity, mood & overall well-being, menopausal discomfort, bone health and skin health.
RESHAW is the largest, longest-running study of its kind with resveratrol. We continue to invest in human clinical studies to contribute to the expanding body of evidence that resveratrol supports healthy living.